Fairvalue-Calculator Fairvalue-Calculator
EN DE

CLIO Cosmetics Co (237880) Fair Value & Analysis

Consumer Defensive · KR · Market cap 188B KRW

Price9,430 KRW
Fair Value17,812 KRW
Upside+88.9%
Quality94/100
Evidence: High Range 14,155 KRW – 21,470 KRW

Fair value as of: Jun 24, 2026

Analysis

CLIO Cosmetics Co (237880) currently trades at 9,430 KRW, while our model-based Fair Value estimate is 17,812 KRW — implying the stock looks roughly 88.9% undervalued today. We read business quality at 94/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

CLIO Cosmetics Co.,Ltd provides makeup products in South Korea and internationally. It offers eye liner and brow, cushion, lipstick, lip tint, shading, cream, skincare mask, hair care products, as well as body and perfumes. The company offers its products under the CLIO, peripera, goodal, DERMATORY, and Healing Bird brands through its CLUB CLIO shopping mall, as well as provides professional services through offline stores and online malls. CLIO Cosmetics Co.,Ltd was founded in 1993 and is based in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is CLIO Cosmetics Co (237880) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 17,812 KRW versus a price of 9,430 KRW — about +89% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 237880?
Our 21-model fair value for CLIO Cosmetics Co is 17,812 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 9,430 KRW.
What is the quality score of 237880?
CLIO Cosmetics Co has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.